Prevalence of GBV-C and hepatitis G virus variants in patients with fulminant hepatic failure in Japan

Journal of Hepatology

Volumn 27, Issue 6, 1997, Pages 966-972

  Tanaka, Motoharu ^a   Nishiguchi, Shuhei ^a   Tanaka, Takashi ^a   Enomoto, Masaru ^a   Fukuda, Katsuhiko ^a   Takeda, Tadashi ^a   Nakajima, Shinya ^a   Shiomi, Susumu ^a   Kuroki, Tetsuo ^a   Monna, Takeyuki ^a   Yano, Yoshihisa ^a   Otani, Shuzo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Fulminant hepatic failure; GB virus C; Hepatitis G virus; Japan

Indexed keywords

ANTINEOPLASTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATIC ENCEPHALOPATHY; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS G VIRUS; HEPATITIS VIRUS; HUMAN; JAPAN; LIVER FAILURE; LIVER TOXICITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

EID: 0030781277     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80138-9     Document Type: Article

References (39)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 3:1970;282-298.
2. Bernuau J, Rueff B, Benhamou J-P. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 6:1986;97-106.
3. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 342:1993;273-275.
4. Tibbs C, Williams R. Viral causes and management of acute liver failure. J Hepatol. 22:1995;68-73. (suppl. 1).
5. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
6. Muto Y, Sugihara J, Ohnishi H, Moriwaki H, Nishioka K. Anti-hepatitis C virus antibody prevails in fulminant hepatic failure. Gastroenterol Jpn. 25:1990;32-35.
7. Yanagi M, Kaneko S, Unoura M, Murakami S, Kobayashi K, Sugihara J, et al. Hepatitis C virus in fulminant hepatic failure. N Engl J Med. 324:1991;1895-1896.
8. Ohnishi H, Muto Y, Sakai T, Sugihara J, Harase I, Moriwaki H. Hepatitis C virus infection involved in fulminant hepatitis in Japan. Int Hepatol Commun. 2:1994;347-351.
9. Féray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology. 104:1993;549-555.
10. Liang TJ, Jeffers L, Reddy RK, Silva MO, Cheinquer H, Findor A, et al. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology. 104:1993;556-562.
11. Kuwada SK, Patel VM, Hollinger FB, Lin HJ, Yarbough PO, Wiesner RH, et al. Non-A, non-B fulminant hepatitis is also non-E and non-C. Am J Gastroenterol. 89:1994;57-61.
12. Fagan EA, Harrison TJ. Exclusion in liver by polymerase chain reaction of hepatitis B and C viruses in acute liver failure attributed to sporadic non-A, non-B hepatitis. J. Hepatol. 21:1994;587-591.
13. Mutimer D, Shaw J, Neuberger J, Skidmore S, Martin B, Hubscher S, et al. Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis. Gut. 36:1995;433-436.
14. Villamil FG, Hu K-Q, Yu C-H, Lee C-H, Rojter SE, Podesta LG, et al. Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure. Hepatology. 22:1995;1379-1386.
15. Deinhardt F, Holmes AW, Capps RB, Popper H. Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med. 125:1967;673-687.
16. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA. 92:1995;3401-3405.
17. Schlauder GG, Dawson GJ, Simons JN, Pilot-Matias TJ, Gutierrez RA, Heynen CA, et al. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol. 46:1995;81-90.
18. Muerhoff AS, Leary TP, Simons JN, Pilot-Matias TJ, Dawson GJ, Erker JC, et al. Genomic organization of GB vriuses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol. 69:1995;5621-5630.
19. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med. 1:1995;564-569.
20. Zuckerman AJ. The new GB hepatitis viruses. Lancet. 345:1995;1453-1454.
21. Linnen J, Wages J Jr, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 271:1996;505-508.
22. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody againstt e antigen. J Virol. 64:1990;1298-1303.
23. Nishiguchi S, Kuroki T, Ueda T, Fukuda K, Takeda T, Nakajima S, et al. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Ann Intern Med. 116:1992;21-25.
24. Reyes GR, Purdy MA, Kim JP, Luk K-C, Young LM, Fry KE, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 247:1990;1335-1339.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
26. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 239:1988;487-491.
27. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet. 346:1995;1131-1132.
28. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 339:1989;237-238.
29. Erratum Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 339:1989;490.
30. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Böker K, Muerhoff S, et al. Association between fulminant hepatic failure and a stain of GBV virus C. Lancet. 348:1996;1626-1629.
31. Kao J-H, Chen P-J, Chen D-S. GBV-C in the aetiology of fulminant hepatitis. Lancet. 347:1996;120.
32. Kuroki T, Nishiguchi S, Tanaka M, Enomoto M, Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan? Lancet. 347:1996;908.
33. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med. 334:1996;1485-1490.
34. Sáiz JC, Sans M, Olmedo E, López-Labrador FX, Restrepo JC, Rimola A, et al. Hepatitis G virus infection in fulminant hepatitis [abstract]. Hepatology. 24:1996;292. (suppl.).
35. Munoz S, Alter H, Liang TJ, Nakatsuji Y, Shih J, Reddy R, et al. Hepatitis G virus is present in serum of patients with fulminant hepatitis of unknown etiology [abstract]. Hepatology. 24:1996;293. (suppl.).
36. Haydon GH, Jarvis LM, Simmonds P, Simpson KJ, Hayes PC. Clinical significance of the detection of GBV-C virus in the serum of patients with acute liver failure of unknown aetiology [abstract]. Hepatology. 24:1996;292. (suppl.).
37. Mishiro S, Yoshiba M, Okamoto H. GBV-C in the aetiology of fulminant hepatitis. Lancet. 347:1996;120-121.
38. Kosaka Y, Takase K, Kojima M, Shimizu M, Inoue K, Yoshiba M, et al. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology. 100:1991;1087-1094.
39. Alter HJ. The cloning and clinical implications of GBV-C/HGV and HGBV-C. N Engl J Med. 334:1996;1536-1537.